Abstract
Persistent seroma following breast cancer surgery causes morbidity and delays adjuvant treatment. Sclerotherapy helps in managing recalcitrant seromas. We evaluated efficacy of 10% povidone iodine sclerotherapy treatment for persistent seromas after breast cancer surgery. Persistent drainage of > 100 mL/day 15 days following surgery, and seromas that required aspiration > 100 mL/week 2 weeks after drain removal, was considered for 10% povidone sclerotherapy in a non-randomized observational study. Resolution (drain output < 20 mL/day), treatment days, recurrence, and complications were assessed as measures of efficacy. Descriptive measures of central tendency and dispersion were reported. The relationship of the seroma quantity with risk factors (age, body mass index, levels and number of axillary lymph nodes dissected, neoadjuvant chemotherapy) and efficacy was analysed. We examined the correlation using Pearson and Spearman’ signed rank, Student’s t, and Mann–Whitney U-tests, to compare the means. Of 14/312 (4.5%) patients with persistent seroma, 13 (92.8%) had complete resolution after sclerotherapy within 6.71 days (range: 6–8). AC (p = 0.04), neoadjuvant chemotherapy (NACT) (p = 0.005), and number of nodes harvested without NACT (p = 0.025) were significantly associated with the quantity of discharge, while age (p = 0.072), body mass index (p = 0.432), type of surgery (breast conservation surgery vs. modified radical mastectomy) (p = 0.28), and total number of axillary lymph nodes (p = 0.679) were not. When used in this unique innovative manner, 10% povidone iodine sclerotherapy was found to be very effective (93%), minimally invasive, and safe in our study, and therefore appears to be an ideal sclerosing agent.
Similar content being viewed by others
References
Kumar S, Lal B, Misra MC (1995) Post-mastectomy seroma: a new look into the aetiology of an old problem. J R Coll Surg Edin 40:292–294
Throckmorton AD, Askegard-Giesmann J, Hoskin TL, Bjarnason H, Donohue JH, Boughey JC, Degnim AC (2008) Sclerotherapy for the treatment of post mastectomy seroma. Am J Surg 196:541–544. https://doi.org/10.1002/(sici)1096-9098(200004)73:4%3C224:aid-jso7%3E3.0.co;2-0
Oertli D, Laffer U, Haberthuer F, Kreuter U, Harder F (1994) Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer. Br J Surg 81:856–859. https://doi.org/10.1002/bjs.1800810621
Li H, Zhang F, Lei G (2014) Morel-Lavallee lesion. Chin Med J (Engl) 127:1351–1356
Bryant M, Baum M (1987) Postoperative seroma following mastectomy and axillary dissection. Br J Surg 74:1187. https://doi.org/10.1002/bjs.1800741239
Willett WC, Rockhill B, Hankinson SE, Hunter DJ, Colditz GA (2000) Epidemiology and nongenetic causes of breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 175–220
Watt-Boolsen S, Nielsen VB, Jensen J, Bak S (1989) Postmastectomy seroma. A study of the nature and origin of seroma after mastectomy. Dan Med Bull 36:487–489
Porter KA, O’Connor S, Rimm E, Lopez M (1998) Electrocautery as a factor in seroma formation following mastectomy. Am J Surg 176:8–11. https://doi.org/10.1016/s0002-9610(98)00093-2
O’Dwyer PJ, O’Higgins NJ, James AG (1991) Effect of closing dead space on incidence of seroma after mastectomy. Surg Gynecol Obstet 172:55–56
Dawson I, Stam L, Heslinga JM, Kalsbeek HL (1989) Effect of shoulder immobilization on wound seroma and shoulder dysfunction following modified radical mastectomy: a randomized prospective clinical trial. Br J Surg 76:311–312. https://doi.org/10.1002/bjs.1800760329
Yii M, Murphy C, Orr N (1995) Early removal of drains and discharge of breast cancer surgery patients: a controlled prospective clinical trial. Ann R Coll Surg Engl 77:377–379
Janis JE, Khansa L, Khansa I (2016) Review strategies for postoperative seroma prevention: a systematic review. Plast Reconstr Surg 138:240–252. https://doi.org/10.1097/prs.0000000000002245
Saeb-Parsy K, Athanassoglou V, Benson JR (2006) Talc seromadesis: a novel technique for the treatment of chronic seromas following breast surgery. Breast J 12:502–504. https://doi.org/10.1111/j.1075-122x.2006.00317.x
Agarwal R, Aggarwal AN, Gupta D (2006) Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy. Respirology 11:105–108. https://doi.org/10.1111/j.1440-1843.2006.00792.x
Ibnatya A1, Tazi K, Koutani A, Khader K, ElMamoun M, Hachimi M, Lakrissa A (1995) Sclerotherapy with Betadine for simple cysts of the kidney. J Urol (Paris) 101:237–239
Mahrer A, Ramchandani P, Trerotola S, Shlansky-Goldberg R, Itkin M (2010) Sclerotherapy in the management of postoperative lymphocele. J Vasc Interv Radiol 21:1050–1053. https://doi.org/10.1016/j.jvir.2010.03.014
Singh KJ, Srivastava A (2005) Nonsurgical management of chyluria (sclerotherapy). Indian J of Urol 21:55–58
Lachapelle JM (2005) Allergic contact dermatitis from povidone-iodine: a re-evaluation study. Contact Dermatitis 52:9–10. https://doi.org/10.1111/j.0105-1873.2005.00479.x
Vermeulen H, Westerbos SJ, Ubbink DT (2010) Benefit and harm of iodine in wound care: a systematic review. J Hosp Infect 76:191–199. https://doi.org/10.1016/j.jhin.2010.04.026
Penaud A, Quignon R, Danin A, Bahé L, Zakine G (2011) Alcohol sclerodhesis: an innovative treatment for chronic Morel-Lavallée lesions. J Plast Reconstr Aesthet Surg 64:e262–e264. https://doi.org/10.1016/j.bjps.2011.06.012
Moritz RK, Reich-Schupke S, Altmeyer P, Stücker M (2013) Polidocanol foam sclerotherapy of persisting postoperative seromas after varicose vein surgery: a series of six cases. Phlebology 28:341–346. https://doi.org/10.1258/phleb.2012.011152
Cheng J (2015) Doxycycline sclerotherapy in children with head and neck lymphatic malformations. J Pediatr Surg 50:2143–2146. https://doi.org/10.1016/j.jpedsurg.2015.08.051
Olímpio Hde O, Bustorff-Silva J, Oliveira Filho AG, Araujo KC (2014) Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children. Clinics (Sao Paulo) 69(8):505–508. https://doi.org/10.6061/clinics/2014(08)01
Berkoff DJ, Kanaan M, Kamath G (2013) Fibrin glue as a non-invasive outpatient treatment for post-arthroscopic knee seromas. Knee Surg Sports Traumatol Arthrosc 21:1922–1924. https://doi.org/10.1007/s00167-013-2505-0
Olímpio Hde O, Bustorff-Silva J, Oliveira Filho AG, Araujo KC (2014) Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children. Clinics (Sao Paulo) 69:505–508. https://doi.org/10.6061/clinics/2014(08)01
Sitzmann JV, Dufresne C, Zuidema GD (1983) The use of sclerotherapy for treatment of postmastectomy wound seromas. Surgery 93:345–347
McCarthy PM, Martin JK Jr, Wells DC, Welch JS, Ilstrup DM (1986) An aborted, prospective, randomized trial of sclerotherapy for prolonged drainage after mastectomy. Surg Gynecol Obstet 162:418–420
Carcoforo P, Soliani G, Maestroni U, Donini A, Inderbitzin D, Hui TT, Lefor A, Avital I, Navarra GJ (2003) Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial. Am Coll Surg 196:365–369. https://doi.org/10.1016/s1072-7515(02)01757-x
Ramkumar A (2019) Doxycycline sclerotherapy to manage seroma following breast cancer surgery. Indian J Surg Oncol 2019:1–2. https://doi.org/10.1007/s13193-019-00982-x
Acknowledgements
The author would like to thank Dr Amritanshu Ram, PhD (Department of Clinical Excellence, Health Care Global Cancer Hospital), and Dr Raghavendra Rao, BNYS, PhD (Department of Clinical Excellence, Health Care Global Cancer Hospital), for their invaluable help in statistical analysis.
Author information
Authors and Affiliations
Contributions
RCS: Conceptualization, formal analysis and investigation, writing — original draft preparation, writing — review and editin, resources. MB: conceptualization, writing — review and editing, supervision, resources. VP: methodology, writing — review and editing. KGT: methodology. NSG: methodology.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing intersts.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mahesh Bandimegal is a co-author of this work.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sanjeeviah, R.C., Bandimegal, M., Patil, V. et al. Povidone Iodine Sclerotherapy for the Treatment of Persistent Seromas after Breast Cancer Surgery. Indian J Surg Oncol 14, 81–87 (2023). https://doi.org/10.1007/s13193-022-01629-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-022-01629-0